Sexual Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2114983, encodeId=ade9211498365, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：性健康 经验分享：Submitted (07-Jul-2022) Major Revision (13-Sep-2022) R1 Submitted (17-Nov-2022) Minor Revision (22-Dec-2022) R2 Submitted (08-Jan-2023) Accept (10-Jan-2023) 一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。 可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30a06468461, createdName=ms2000000647637496, createdTime=Thu Feb 16 22:00:44 CST 2023, time=2023-02-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1106293, encodeId=98461106293ce, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106294, encodeId=21cf1106294e8, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571037, encodeId=bdab5e103732, content=您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, beContent=xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=Xanl8iahTVvelQztJwAt8Bw&s=100, createdBy=6bd62557731, createdName=Crystal12345, createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846064, encodeId=4ec88460648a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Thu Aug 09 17:13:41 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549549, encodeId=994d5495493e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：还是比较好投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bba36857, createdName=xuebinfen, createdTime=Tue Nov 28 12:50:00 CST 2017, time=2017-11-28, status=1, ipAttribution=)]

2023-02-16 ms2000000647637496 来自湖南省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：性健康
经验分享：Submitted (07-Jul-2022)
Major Revision (13-Sep-2022)
R1 Submitted (17-Nov-2022)
Minor Revision (22-Dec-2022)
R2 Submitted (08-Jan-2023)
Accept (10-Jan-2023)

一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。

可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114983, encodeId=ade9211498365, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：性健康 经验分享：Submitted (07-Jul-2022) Major Revision (13-Sep-2022) R1 Submitted (17-Nov-2022) Minor Revision (22-Dec-2022) R2 Submitted (08-Jan-2023) Accept (10-Jan-2023) 一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。 可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30a06468461, createdName=ms2000000647637496, createdTime=Thu Feb 16 22:00:44 CST 2023, time=2023-02-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1106293, encodeId=98461106293ce, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106294, encodeId=21cf1106294e8, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571037, encodeId=bdab5e103732, content=您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, beContent=xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=Xanl8iahTVvelQztJwAt8Bw&s=100, createdBy=6bd62557731, createdName=Crystal12345, createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846064, encodeId=4ec88460648a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Thu Aug 09 17:13:41 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549549, encodeId=994d5495493e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：还是比较好投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bba36857, createdName=xuebinfen, createdTime=Tue Nov 28 12:50:00 CST 2017, time=2017-11-28, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

文章投稿应该按照什么思路开始？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114983, encodeId=ade9211498365, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：性健康 经验分享：Submitted (07-Jul-2022) Major Revision (13-Sep-2022) R1 Submitted (17-Nov-2022) Minor Revision (22-Dec-2022) R2 Submitted (08-Jan-2023) Accept (10-Jan-2023) 一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。 可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30a06468461, createdName=ms2000000647637496, createdTime=Thu Feb 16 22:00:44 CST 2023, time=2023-02-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1106293, encodeId=98461106293ce, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106294, encodeId=21cf1106294e8, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571037, encodeId=bdab5e103732, content=您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, beContent=xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=Xanl8iahTVvelQztJwAt8Bw&s=100, createdBy=6bd62557731, createdName=Crystal12345, createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846064, encodeId=4ec88460648a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Thu Aug 09 17:13:41 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549549, encodeId=994d5495493e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：还是比较好投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bba36857, createdName=xuebinfen, createdTime=Tue Nov 28 12:50:00 CST 2017, time=2017-11-28, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

我的文章大概有几分？

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114983, encodeId=ade9211498365, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：性健康 经验分享：Submitted (07-Jul-2022) Major Revision (13-Sep-2022) R1 Submitted (17-Nov-2022) Minor Revision (22-Dec-2022) R2 Submitted (08-Jan-2023) Accept (10-Jan-2023) 一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。 可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30a06468461, createdName=ms2000000647637496, createdTime=Thu Feb 16 22:00:44 CST 2023, time=2023-02-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1106293, encodeId=98461106293ce, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106294, encodeId=21cf1106294e8, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571037, encodeId=bdab5e103732, content=您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, beContent=xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=Xanl8iahTVvelQztJwAt8Bw&s=100, createdBy=6bd62557731, createdName=Crystal12345, createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846064, encodeId=4ec88460648a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Thu Aug 09 17:13:41 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549549, encodeId=994d5495493e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：还是比较好投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bba36857, createdName=xuebinfen, createdTime=Tue Nov 28 12:50:00 CST 2017, time=2017-11-28, status=1, ipAttribution=)]

2019-05-16 Crystal12345

您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表:
还是比较好投的

xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的

185 0

[GetPortalCommentsPageByObjectIdResponse(id=2114983, encodeId=ade9211498365, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：性健康 经验分享：Submitted (07-Jul-2022) Major Revision (13-Sep-2022) R1 Submitted (17-Nov-2022) Minor Revision (22-Dec-2022) R2 Submitted (08-Jan-2023) Accept (10-Jan-2023) 一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。 可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30a06468461, createdName=ms2000000647637496, createdTime=Thu Feb 16 22:00:44 CST 2023, time=2023-02-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1106293, encodeId=98461106293ce, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106294, encodeId=21cf1106294e8, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571037, encodeId=bdab5e103732, content=您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, beContent=xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=Xanl8iahTVvelQztJwAt8Bw&s=100, createdBy=6bd62557731, createdName=Crystal12345, createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846064, encodeId=4ec88460648a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Thu Aug 09 17:13:41 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549549, encodeId=994d5495493e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：还是比较好投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bba36857, createdName=xuebinfen, createdTime=Tue Nov 28 12:50:00 CST 2017, time=2017-11-28, status=1, ipAttribution=)]

2018-08-09 ms982570025122324

审稿速度:1.0 | 投稿命中率:75.0
经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错

105 0

[GetPortalCommentsPageByObjectIdResponse(id=2114983, encodeId=ade9211498365, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：性健康 经验分享：Submitted (07-Jul-2022) Major Revision (13-Sep-2022) R1 Submitted (17-Nov-2022) Minor Revision (22-Dec-2022) R2 Submitted (08-Jan-2023) Accept (10-Jan-2023) 一开始是投的Journal of Sexual Medicine (同一个出版社，JCR 2区)，被建议转投这个期刊Sexual Medicine (JCR 3区)。 可能因为是季刊，所以速度不是很快。但Editor和AE都非常友好，一直以鼓励的态度给出意见，但不影响提出的修改建议一针见血，帮助我们极大地提高了稿件质量。不过OA费用有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30a06468461, createdName=ms2000000647637496, createdTime=Thu Feb 16 22:00:44 CST 2023, time=2023-02-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1106293, encodeId=98461106293ce, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106294, encodeId=21cf1106294e8, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571037, encodeId=bdab5e103732, content=您好，请问年文章数这么少，还好中吗？xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, beContent=xuebinfen 2017-11-28 12:50:00 发表: 还是比较好投的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=Xanl8iahTVvelQztJwAt8Bw&s=100, createdBy=6bd62557731, createdName=Crystal12345, createdTime=Thu May 16 00:00:00 CST 2019, time=2019-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846064, encodeId=4ec88460648a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：内科杂志挺多的，不过第一次投稿，没有太多经验就不敢投很高的，还好很快就给了审稿意见，修改后就接受了，感觉自己运气不错 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Thu Aug 09 17:13:41 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549549, encodeId=994d5495493e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：还是比较好投的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bba36857, createdName=xuebinfen, createdTime=Tue Nov 28 12:50:00 CST 2017, time=2017-11-28, status=1, ipAttribution=)]

2017-11-28 xuebinfen

审稿速度:3.0 | 投稿命中率:50.0
经验分享：还是比较好投的

260 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务